SCR-LIP-000782 · Claim · machine-readable JSON →
Comorbid fibromyalgia may be associated with further reduced quality of life and more anxiety and depression in lipedema.
General proposition consolidated from 1 earlier single-paper claims; each study's own result is shown as its finding.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- low (GRADE)
- Evidence
- 1 source(s)
- Answers
- 1 question(s)
- Dates
- 2026-11-20 → 2026-11-20
Structured evidence, machine-compiled — not a verdict.
Evidence over time
Evidence (1)
- Prevalence of Fibromyalgia Syndrome in Women with Lipedema and Its Effect on Anxiety, Depression, and Quality of Life — Cagliyan Turk et al. (2024) ✓ verified — consistent · cross sectional · 2024 · reading confidence: moderate
In 354 women, those with fibromyalgia (35%) had higher anxiety (13.11 vs 9.87) and depression (10.23 vs 8.26) and lower SF-12 physical (35.37 vs 42.55) and mental (35.27 vs 40.38) scores (p<0.001).
Online self-administered survey of lipedema patients reports quality of life, anxiety, and depression measures (HADS, SF-12), directly addressing the question, though stratified primarily by FMS comorbidity rather than lipedema vs controls.
Context (PECO)
Answers these questions
Gaps & caveats
Change log
- 2026-11-20 — created_by_consolidation · general proposition consolidated from SQ-LIP-000041